References
- Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility pattern. Rev Infect Dis 1988; 10: 867–78
- Shah PW, Stille W. Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. J Antimicrobiol Chemother 1983; 11: 597–8
- Jacoby GA, Medeiros AA, O'Brien TF, Pinto ME, Jiang H. Broad-spectrum, transmissible beta-lactamases. N Engl J Med 1988; 319: 723–4
- Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 1451–6
- Diekema DJ, Pfaller MA, Jones RN, Doem GV, Winokur PL, Gales AC, et al. Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program 1997. Clin Infect Dis 1999; 29: 595–607
- MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM- and SHV- derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect 2002; 8: 715–24
- Philippon A, Arlet G, Lagrance PH. Origin and impact of plasmid-mediated extended- spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13: 17–29
- Çağatay AA, Kocagöz T, Eraksoy H. Dio-sensimedia: a novel culture medium for rapid detection of extended-spectrum beta-lactamases. BMC Infectious Diseases 2003; 3: 22
- Kocagöz T, Ercis S, Darka Ö, Salmanzadeh-Ahrabi S, Kocagöz S, Hasçelik G. Quicolor: a novel system for rapid antibacterial susceptibility testing. Ann Microbiol 2007; 57: 131–5
- Clinical and Laboratory Standards Institute (formerly NCCLS). Performance Standards for Antimicrobial susceptibility Testing; Fifteenth Informational Supplement: M100-S15. CLSI, Wayne, PAUSA, 2005.
- Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249–55
- Muratani T, Kobayashi T, Matsumoto T. Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan. Int J Antimicrob Agents 2006; 27: 491–9
- Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999; 37: 1415–8
- Doern G, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994; 32: 1757–62
- Schifman R, Pindur A, Bryan JA. Laboratory practices for reporting bacterial susceptibility tests that affect antibiotic therapy. Arch Pathol Lab Med 1997; 121: 1168–70
- Granato PA. Impact of same-day tests versus traditional overnight testing. Diagn Microbiol Infect Dis 1993; 16: 237–43
- Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–84
- Matar GM, Al Khodor S, El-Zaatari M, Uwaydah M. Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Ann Trop Med Parasitol 2005; 99: 413–7
- Ho PL, Ho AY, Chow KH, Wong RC, Duan RS, Ho WL, et al. Occurrence and molecular analysis of extended-spectrum beta-lactamase-producing Proteus mirabilis in Hong Kong, 1999–2002. J Antimicrob Chemother 2005; 55: 840–5
- D'Azevedo PA, Goncalves AL, Musskopf MI, Ramos CG, Dias CA. Laboratory tests in the detection of extended-spectrum beta-lactamase production: National Committee for Clinical Laboratory Standards (NCCLS) screening test, the E-test, the double disk confirmatory test, and cefoxitin susceptibility testing. Braz J Infect Dis 2004; 8: 372–7
- Linscott AJ, Brown WJ. Evaluation of 4 commercially available extended-spectrum beta-lactamase phenotypic confirmation tests. J Clin Microbiol 2005; 43: 1081–5
- Sturenburg E, Sobottka I, Noor D, Laufs R, Mack D. Evaluation of a new cefepime-clavulanate ESBL E-test to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J Antimicrob Chemother 2004; 54: 134–8